Amphotropic mouse retroviruses will be engineered to serve as vectors for introducing genes into hematopoietic stem cells more efficiently. Studies will be carried out with mouse and human bone marrow. Conditions for optimizing infectivity of viruses will be studied by using """"""""crippled"""""""" strains containing inserted neomycin-resistance gene and glucocerebrosidase cDNA. Expression of human glucocerebrosidase in mouse hematopoietic stem cells will be demonstrated with mouse-mouse monoclonal antibodies. In the case of human cells, attempts will be made to demonstrate expression of the gene by both immunologic and activity measurements, using cultured fibroblasts and bone marrow stem cells from patients with Gaucher disease as a target. The reagents developed in these investigations, the DNA probes and antibodies, will be used to determine whether messenger RNA is formed in Gaucher disease cells, to study the possible linkage of various types of Gaucher genes to restriction polymorphisms, to investigate whether processing of glucocerebrosidase occurs and whether such processing is helpful in distinguishing different types of Gaucher disease. cDNA from patients with the different types of Gaucher disease will be sequenced to determine whether specific portions of the molecule are involved in specific disease types and to provide better understanding of the degree of diversity of Gaucher's disease within the Jewish population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK036639-03
Application #
3235121
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1986-07-01
Project End
1991-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92037
Beutler, E; Gelbart, T (1996) Glucocerebrosidase (Gaucher disease). Hum Mutat 8:207-13
Beutler, E; Baronciani, L (1996) Mutations in pyruvate kinase. Hum Mutat 7:1-6
Beutler, E; Gelbart, T; Balicki, D et al. (1996) Gaucher disease: four families with previously undescribed mutations. Proc Assoc Am Physicians 108:179-84
Beutler, E (1995) Gaucher disease. Adv Genet 32:17-49
Zimran, A; Elstein, D; Abrahamov, A et al. (1995) Prenatal molecular diagnosis of Gaucher disease. Prenat Diagn 15:1185-8
Beutler, E; Gelbart, T; Demina, A et al. (1995) Five new Gaucher disease mutations. Blood Cells Mol Dis 21:20-4
Balicki, D; Beutler, E (1995) Gaucher disease. Medicine (Baltimore) 74:305-23
Beutler, E; Kuhl, W; Vaughan, L M (1995) Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages. Mol Med 1:320-4
Beutler, E; Demina, A; Laubscher, K et al. (1995) The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Blood Cells Mol Dis 21:86-108
Beutler, E; Gelbart, T (1994) Two new Gaucher disease mutations. Hum Genet 93:209-10

Showing the most recent 10 out of 46 publications